We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LPP:GPWLPP S.A. Analysis

Data as of 2026-03-11 - not real-time

IDR 1,830.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at IDR 1,830, just below the 20‑day SMA (1,896) and the 50‑day SMA (1,844) but above the 200‑day SMA (1,716), indicating a short‑term pull‑back within a longer‑term bullish framework. Volume is on the rise, the RSI sits at 44 % (neutral), while the MACD histogram is negative, signaling lingering bearish momentum. The price is near the identified support of 1,800 and faces resistance around 1,960, providing a clear technical range.
Fundamentally, the company boasts a very low trailing PE of 5.6 and a striking dividend yield of 16.2 % with a payout ratio of 93 %, yet its debt‑to‑equity ratio exceeds 940 % and total debt dwarfs cash reserves, raising concerns about leverage sustainability. Despite a solid free cash flow generation of IDR 1.14 trillion, revenue is contracting at –8.3 % and the price‑to‑book ratio is elevated at 14.9×, suggesting the market may be pricing in the balance‑sheet risk. The DCF model implies a fair value far above the current price, but the “Extreme Greed” market sentiment (fear‑greed index 75.6) and high 30‑day volatility (28 %) add caution to the upside narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above the 1,800 support level
  • Bearish MACD histogram despite overall bullish trend
  • High dividend yield offering immediate income

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Low PE ratio indicating significant valuation headroom
  • DCF fair‑value estimate far above current market price
  • Increasing trading volume supporting potential price appreciation

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Elevated debt‑to‑equity ratio posing balance‑sheet risk
  • Negative revenue growth offset by strong free cash flow
  • Sustained high dividend yield but questionable payout sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth-8.30%
Profit Margin12.54%
P/E Ratio5.6
ROE242.32%
ROA13.77%
Debt/Equity941.70
P/B Ratio14.9
Op. Cash FlowIDR1667.5B
Free Cash FlowIDR1135.5B

Technical Analysis

TrendBullish
RSI43.7
SupportIDR 1,800.00
ResistanceIDR 1,960.00
MA 20IDR 1,896.25
MA 50IDR 1,844.40
MA 200IDR 1,716.10
MACDBearish
VolumeIncreasing
Fear & Greed Index75.57

Valuation

Fair ValueIDR 11,660.86
Target PriceIDR 1,662.50
Upside/Downside-9.15%
GradeUndervalued
TypeValue
Dividend Yield16.22%

Risk Assessment

Beta0.52
Volatility28.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.